These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11731627)

  • 21. Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial.
    Fischer TF; Singer AJ
    Acad Emerg Med; 1999 Sep; 6(9):895-9. PubMed ID: 10490250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Chyka PA; Erdman AR; Manoguerra AS; Christianson G; Booze LL; Nelson LS; Woolf AD; Cobaugh DJ; Caravati EM; Scharman EJ; Troutman WG;
    Clin Toxicol (Phila); 2007 Sep; 45(6):662-77. PubMed ID: 17849242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Container residue after activated charcoal administration in the emergency department.
    Harchelroad F
    Vet Hum Toxicol; 1992 Feb; 34(1):13-4. PubMed ID: 1621355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative approaches to the administration of activated charcoal in pediatric toxic ingestions.
    West L
    Pediatr Nurs; 1997; 23(6):616-9. PubMed ID: 9429522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How feasible is it to conform to the European guidelines on administration of activated charcoal within one hour of an overdose?
    Karim A; Ivatts S; Dargan P; Jones A
    Emerg Med J; 2001 Sep; 18(5):390-2. PubMed ID: 11559618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical charcoal for a child's poisoning at home: availability and success of administration in Finland.
    Lamminpää A; Vilska J; Hoppu K
    Hum Exp Toxicol; 1993 Jan; 12(1):29-32. PubMed ID: 8094967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Container residue after the administration of aqueous activated charcoal products.
    Krenzelok EP; Lush RM
    Am J Emerg Med; 1991 Mar; 9(2):144-6. PubMed ID: 1994942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management.
    Wax PM; Erdman AR; Chyka PA; Keyes DC; Caravati EM; Booze L; Christianson G; Woolf A; Olson KR; Manoguerra AS; Scharman EJ; Troutman WG
    Clin Toxicol (Phila); 2005; 43(3):131-46. PubMed ID: 15906457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of activated charcoal on drug exposure in healthy volunteers: a meta-analysis.
    Jürgens G; Hoegberg LC; Graudal NA
    Clin Pharmacol Ther; 2009 May; 85(5):501-5. PubMed ID: 19194372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs.
    Koenigshof AM; Beal MW; Poppenga RH; Jutkowitz LA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(5):606-10. PubMed ID: 25891141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home syrup of ipecac use does not reduce emergency department use or improve outcome.
    Bond GR
    Pediatrics; 2003 Nov; 112(5):1061-4. PubMed ID: 14595046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Activated Charcoal on Rivaroxaban Complex Absorption.
    Ollier E; Hodin S; Lanoiselée J; Escal J; Accassat S; De Magalhaes E; Basset T; Bertoletti L; Mismetti P; Delavenne X
    Clin Pharmacokinet; 2017 Jul; 56(7):793-801. PubMed ID: 27910037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single dose activated charcoal for gut decontamination: Application by medical non-professionals -a prospective study on availability and practicability.
    Pfab R; Schmoll S; Dostal G; Stenzel J; Hapfelmeier A; Eyer F
    Toxicol Rep; 2017; 4():49-54. PubMed ID: 28959624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?
    Isbister GK; Dawson AH; Whyte IM
    Emerg Med J; 2003 Jul; 20(4):375-8. PubMed ID: 12835364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for emesis after therapeutic use of activated charcoal in acutely poisoned children.
    Osterhoudt KC; Durbin D; Alpern ER; Henretig FM
    Pediatrics; 2004 Apr; 113(4):806-10. PubMed ID: 15060231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does transportation by ambulance decrease time to gastrointestinal decontamination after overdose?
    Wolsey BA; McKinney PE
    Ann Emerg Med; 2000 Jun; 35(6):579-84. PubMed ID: 10828771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose.
    Spiller HA; Winter ML; Klein-Schwartz W; Bangh SA
    J Emerg Med; 2006 Jan; 30(1):1-5. PubMed ID: 16434328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of prokinetics on the gastrointestinal transit and residence times of activated charcoal.
    Orisakwe OE; Afonne OJ; Ilondu NA; Obi E; Ufearo CS; Agbasi PU; Maduka SO; Orish CN; Orish VN
    J Pak Med Assoc; 2002 Aug; 52(8):354-6. PubMed ID: 12481675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use and knowledge of single dose activated charcoal: A survey of Australian doctors.
    Corcoran G; Chan B; Chiew A
    Emerg Med Australas; 2016 Oct; 28(5):578-85. PubMed ID: 27555040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine ingestions in children: a report from poison centers.
    Spiller HA; Lintner CP; Winter ML
    Ann Pharmacother; 2005 Jun; 39(6):1045-8. PubMed ID: 15870137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.